Invasive Candida infections in the neonate

Adler-Shohet, 2001, Amphotericin b lipid complex for neonatal invasive candidiasis, Arch. Dis. Child. Fetal Neonat. Ed., 84, F131, 10.1136/fn.84.2.F131 Annable, 1990, Long-term follow-up of candida endophthalmitis in the premature infant, J. Pediatr. Ophthalmol. Strabismus, 27, 103, 10.3928/0191-3913-19900301-12 Baley, 2003, Neonatal candidiasis: ophthalmologic infection, Semin. Perinatol., 27, 401, 10.1016/S0146-0005(03)00064-8 Baley, 1986, Fungal colonization in the very low birth weight infant, Pediatrics, 78, 225, 10.1542/peds.78.2.225 Baley, 1984, Disseminated fungal infections in very low-birth-weight infants: therapeutic toxicity, Pediatrics, 73, 153, 10.1542/peds.73.2.153 Baley, 1990, Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin b and 5-fluorocytosine in neonates, J. Pediatr., 116, 791, 10.1016/S0022-3476(05)82674-5 Banerjea, 2002, The current role of colony-stimulating factors in prevention and treatment of neonatal sepsis, Semin. Neonatol., 7, 335, 10.1016/S1084-2756(02)90116-8 Bartizal, 1997, In vitro preclinical evaluation studies with the echinocandin antifungal mk-0991 (l-743,872), Antimicrob. Agents Chemother., 41, 2326, 10.1128/AAC.41.11.2326 Bartizal, K., Motyl, M., Hicks, P., Sable, C., Dinoble, M., Kartsonis, N., 2002. In vitro susceptiblility results and correlation with outcome: results from the randomized in candidiasis study of caspofungin vs. amphotericin b. In: Paper presented at the Internscience Conference on Antimicrobial Agents and Chemotherapy (abstract). Bendel, 2003, Colonization and epithelial adhesion in the pathogenesis of neonatal candidiasis, Semin. Perinatol., 27, 357, 10.1016/S0146-0005(03)00059-4 Benjamin, 2004, Mortality following blood culture in premature infants: increased with Gram-negative bacteremia and candidemia, but not Gram-positive bacteremia, J. Perinatol., 24, 175, 10.1038/sj.jp.7211068 Benjamin, 2004, Safety and pharmacokinetics of anidulafungin in pediatric patients with neutropenia Benjamin, 2003, Empirical therapy for neonatal candidemia in very low birth weight infants, Pediatrics, 112, 543, 10.1542/peds.112.3.543 Benjamin, 1999, Candidal mycetoma in the neonatal kidney, Pediatrics, 104, 1126, 10.1542/peds.104.5.1126 Benjamin, 2003, Candida bloodstream infection in neonates, Semin. Perinatol., 27, 375, 10.1016/S0146-0005(03)00061-2 Benjamin, 2003, Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques, Pediatrics, 112, 634, 10.1542/peds.112.3.634 Benjamin, 2000, When to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia, Pediatrics, 106, 712, 10.1542/peds.106.4.712 Benjamin Jr., D.K., Stoll, B.J., Fanaroff, A.A., McDonald, S.A., Oh, W., Higgins, R., et al., in press. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality, and neuro-developmental outcomes at 18–22 months. Pediatrics. Bennett, 1996 Berenguer, 1993, Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection, Diagn. Microbiol. Infect. Dis., 17, 103, 10.1016/0732-8893(93)90020-8 Bernhardt, 1997, Mycological aspects of gastrointestinal microflora, Scand. J. Gastroenterol. Suppl., 222, 102, 10.1080/00365521.1997.11720731 Biyikli, 2004, The longest use of liposomal amphotericin b and 5-fluorocytosine, Pediatr. Nephrol., 19, 801, 10.1007/s00467-004-1463-7 Bliss, 2003, Antifungal pharmacotherapy for neonatal candidiasis, Semin. Perinatol., 27, 365, 10.1016/S0146-0005(03)00060-0 Botas, 1995, Disseminated candidal infections and intravenous hydrocortisone in preterm infants, Pediatrics, 95, 883, 10.1542/peds.95.6.883 Bryant, 1999, Renal candidiasis in neonates with candiduria, Pediatr. Infect. Dis. J., 18, 959, 10.1097/00006454-199911000-00004 Cairo, 1999, A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates, J. Pediatr., 134, 64, 10.1016/S0022-3476(99)70373-2 Calderone, 2002 Chapman, 2000, Persistently positive cultures and outcome in invasive neonatal candidiasis, Pediatr. Infect. Dis. J., 19, 822, 10.1097/00006454-200009000-00003 Chapman, 2003, Invasive neonatal candidiasis: an overview, Semin. Perinatol., 27, 352, 10.1016/S0146-0005(03)00062-4 Christensson, 1997, Diagnosis of invasive candidiasis in neutropenic children with cancer by determination of d-arabinitol/l-arabinitol ratios in urine, J. Clin. Microbiol., 35, 636, 10.1128/JCM.35.3.636-640.1997 Craven, 1979, Excretion pathways of amphotericin b, J. Infect. Dis., 140, 329, 10.1093/infdis/140.3.329 Darmstadt, 2000, Congenital cutaneous candidiasis: clinical presentation, pathogenesis, and management guidelines, Pediatrics, 105, 438, 10.1542/peds.105.2.438 Dismukes, 2003 Driessen, 1996, Fluconazole vs. amphotericin b for the treatment of neonatal fungal septicemia: a prospective randomized trial, Pediatr. Infect. Dis. J., 15, 1107, 10.1097/00006454-199612000-00011 Driks, 1987, Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization, N. Engl. J. Med., 317, 1376, 10.1056/NEJM198711263172204 Eppes, 1989, Outcome of treatment of candidemia in children whose central catheters were removed or retained, Pediatr. Infect. Dis. J., 8, 99 Fairchild, 2002, Neonatal Candida glabrata sepsis: clinical and laboratory features compared with other candida species, Pediatr. Infect. Dis. J., 21, 39, 10.1097/00006454-200201000-00009 Faix, 2003, Central nervous system candidiasis in the high-risk neonate, Semin. Perinatol., 27, 384, 10.1016/S0146-0005(03)00065-X Fanaroff, A., Martin, R., 2002. Neonatal–Perinatal Medicine, vol. 2, seventh ed. Mosby, St. Louis, MO. Fanaroff, 1998, Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The national institute of child health and human development neonatal research network, Pediatr. Infect. Dis. J., 17, 593, 10.1097/00006454-199807000-00004 Fanaroff, 1994, A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National institute of child health and human development neonatal research network, N. Engl. J. Med., 330, 1107, 10.1056/NEJM199404213301602 Fasano, 1994, Fluconazole treatment of neonates and infants with severe fungal infections not treatable with conventional agents, Eur. J. Clin. Microbiol. Infect. Dis., 13, 351, 10.1007/BF01974619 FDA, 2000. Caspofungin Acetate. FDA advisory committee meeting background. Ferrer, 2001, Detection and identification of fungal pathogens by pcr and by its2 and 5.8s ribosomal DNA typing in ocular infections, J. Clin. Microbiol., 39, 2873, 10.1128/JCM.39.8.2873-2879.2001 Fidel, 1999, Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans, Clin. Microbiol. Rev., 12, 80, 10.1128/CMR.12.1.80 Flahaut, 1998, Rapid detection of Candida albicans in clinical samples by DNA amplification of common regions from C. albicans-secreted aspartic proteinase genes, J. Clin. Microbiol., 36, 395, 10.1128/JCM.36.2.395-401.1998 Frattarelli, 2004, Antifungals in systemic neonatal candidiasis, Drugs, 64, 949, 10.2165/00003495-200464090-00003 Friedman, 2000, Systemic candida infection in extremely low birth weight infants: short term morbidity and long-term neurodevelopmental outcome, Pediatr. Infect. Dis. J., 19, 499, 10.1097/00006454-200006000-00002 Gentry, 1983, Latex agglutination test for detection of candida antigen in patients with disseminated disease, Eur. J. Clin. Microbiol., 2, 122, 10.1007/BF02001577 Goenka, 1996, Candida overgrowth after treatment of duodenal ulcer. A comparison of cimetidine, famotidine, and omeprazole, J. Clin. Gastroenterol., 23, 7, 10.1097/00004836-199607000-00003 Goodman, 1992, A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation, N. Engl. J. Med., 326, 845, 10.1056/NEJM199203263261301 Gotzsche, P.C., Johansen, H.K., 2002. Nystatin prophylaxis and treatment in severely immunodepressed patients. Cochrane Database Syst. Rev. (4), CD002033. Groll, 2000, Comparative efficacy and distribution of lipid formulations of amphotericin b in experimental Candida albicans infection of the central nervous system, J. Infect. Dis., 182, 274, 10.1086/315643 Guida, 2003, Platelet count and sepsis in very low birth weight neonates: is there an organism-specific response?, Pediatrics, 111, 1411, 10.1542/peds.111.6.1411 Hajdu, 1997, Preliminary animal pharmacokinetics of the parenteral antifungal agent mk-0991 (l-743,872), Antimicrob. Agents Chemother., 41, 2339, 10.1128/AAC.41.11.2339 Haroon Parupia, 2001, Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants, J. Perinatol., 21, 242, 10.1038/sj.jp.7200531 Heresi, G., Gerstmann, D., Blumer, J., van den Anker, J., Kearns, G., Reed, M., et al., 2003. A pharmacokinetic study of micafungin (fk463) in premature infants (abstract). In: Paper presented at the Pediatric Academic Society, Seattle, Washington. Hernandez, 2004, Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive candida esophagitis, Antimicrob. Agents Chemother., 48, 1382, 10.1128/AAC.48.4.1382-1383.2004 Holt, 1972, The treatment of urinary candidosis with the oral antifungal drugs 5-fluorocytosine and ‘clotrimazole’, Dev. Med. Child. Neurol. Suppl., 27, 70 Hostetter, 1990, The ic3b receptor on Candida albicans: subcellular localization and modulation of receptor expression by glucose, J. Infect. Dis., 161, 761, 10.1093/infdis/161.4.761 Huang, 1998, Association of fungal colonization and invasive disease in very low birth weight infants, Pediatr. Infect. Dis. J., 17, 819, 10.1097/00006454-199809000-00014 Hurley, 1963, Experimental renal moniliasis in the mouse, J. Pathol. Bacteriol., 86, 75, 10.1002/path.1700860109 Huttova, 1998, Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis, Pediatr. Infect. Dis J., 17, 1012, 10.1097/00006454-199811000-00010 Hylander, 1998, Human milk feedings and infection among very low birth weight infants, Pediatrics, 102, 38, 10.1542/peds.102.3.e38 Juster-Reicher, 2003, High-dose liposomal amphotericin b in the therapy of systemic candidiasis in neonates, Eur. J. Clin. Microbiol. Infect. Dis., 22, 603, 10.1007/s10096-003-0993-4 Karlowicz, 2003, Candidal renal and urinary tract infection in neonates, Semin. Perinatol., 27, 393, 10.1016/S0146-0005(03)00063-6 Karlowicz, 2000, Should central venous catheters be removed as soon as candidemia is detected in neonates?, Pediatrics, 106, E63, 10.1542/peds.106.5.e63 Kaufman, 2003, Strategies for prevention of neonatal invasive candidiasis, Semin. Perinatol., 27, 414, 10.1016/S0146-0005(03)00067-3 Kaufman, 2001, Fluconazole prophylaxis against fungal colonization and infection in preterm infants, N. Engl. J. Med., 345, 1660, 10.1056/NEJMoa010494 Kaufman, 2004, Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants, Clin. Microbiol. Rev., 17, 638, 10.1128/CMR.17.3.638-680.2004 Kicklighter, 2001, Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant, Pediatrics, 107, 293, 10.1542/peds.107.2.293 Kim, 2003, Candida dubliniensis infections in a pediatric population: retrospective identification from clinical laboratory isolates of Candida albicans, J. Clin. Microbiol., 41, 3354, 10.1128/JCM.41.7.3354-3357.2003 Klepser, 2001, Antifungal resistance among candida species, Pharmacotherapy, 21, 124S, 10.1592/phco.21.12.124S.34511 Kossoff, 1998, Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases, Pediatr. Infect. Dis. J., 17, 504, 10.1097/00006454-199806000-00014 Kremer, 1992, Systemic candidiasis in babies with retinopathy of prematurity, Graefes Arch. Clin. Exp. Ophthalmol., 230, 592, 10.1007/BF00181784 Lamb, 1997, The mutation t315a in Candida albicans sterol 14alpha-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity, J. Biol. Chem., 272, 5682, 10.1074/jbc.272.9.5682 Lee, 1998, Comparative study of mortality and morbidity in premature infants (birth weight <1250g) with candidemia or candidal meningitis, Clin. Infect. Dis., 27, 559, 10.1086/514712 Lewis, 2001 Lilien, 1978, Candida albicans meningitis in a premature neonate successfully treated with 5-fluorocytosine and amphotericin b: a case report and review of the literature, Pediatrics, 61, 57, 10.1542/peds.61.1.57 Linder, 2003, Treatment of candidaemia in premature infants: comparison of three amphotericin b preparations, J. Antimicrob. Chemother., 52, 663, 10.1093/jac/dkg419 Loeffler, 2001, Nucleic acid sequence-based amplification of aspergillus rna in blood samples, J. Clin. Microbiol., 39, 1626, 10.1128/JCM.39.4.1626-1629.2001 Lopez Sastre, 2003, Neonatal invasive candidiasis: a prospective multicenter study of 118 cases, Am. J. Perinatol., 20, 153, 10.1055/s-2003-40008 Makhoul, 2001, Review of 49 neonates with acquired fungal sepsis: further characterization, Pediatrics, 107, 61, 10.1542/peds.107.1.61 Malloy, 1993, Cloning and expression of the gene from Candida albicans that encodes a high-affinity corticosteroid-binding protein, Proc. Natl. Acad. Sci. USA, 90, 1902, 10.1073/pnas.90.5.1902 Marodi, 1994, Candidacidal mechanisms in the human neonate. Impaired ifn-gamma activation of macrophages in newborn infants, J. Immunol., 153, 5643, 10.4049/jimmunol.153.12.5643 Mecrow, 1994, Infective endocarditis in newborn infants with structurally normal hearts, Acta Paediatr., 83, 35, 10.1111/j.1651-2227.1994.tb12949.x Melville, 1996, Early onset systemic candida infection in extremely preterm neonates, Eur. J. Pediatr., 155, 904, 10.1007/BF02282843 Mittal, 1998, Candida sepsis and association with retinopathy of prematurity, Pediatrics, 101, 654, 10.1542/peds.101.4.654 Mora-Duarte, 2002, Comparison of caspofungin and amphotericin b for invasive candidiasis, N. Engl. J. Med., 347, 2020, 10.1056/NEJMoa021585 Muller, 2000, Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis, J. Antimicrob. Chemother., 46, 338, 10.1093/jac/46.2.338 Murray, 1991, Comparison of the lysis-centrifugation and agitated biphasic blood culture systems for detection of fungemia, J. Clin. Microbiol., 29, 96, 10.1128/JCM.29.1.96-98.1991 Nguyen, 1996, The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance, Am. J. Med., 100, 617, 10.1016/S0002-9343(95)00010-0 Ninane, 1994, A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre study group, Eur. J. Clin. Microbiol. Infect. Dis., 13, 330, 10.1007/BF01974614 Noyola, 2001, Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia, Clin. Infect. Dis., 32, 1018, 10.1086/319601 Obayashi, 1995, Plasma (1→3)-beta-d-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes, Lancet, 345, 17, 10.1016/S0140-6736(95)91152-9 Odabasi, 2004, Beta-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome, Clin. Infect. Dis., 39, 199, 10.1086/421944 Odio, 2004, Caspofungin therapy of neonates with invasive candidiasis, Pediatr. Infect. Dis. J., 23, 1093 Pera, 2002, Dexamethasone therapy and candida sepsis in neonates less than 1250g, J. Perinatol., 22, 204, 10.1038/sj.jp.7210699 Pfaller, 1994, Epidemiology and control of fungal infections, Clin. Infect. Dis., 19, S8, 10.1093/clinids/19.Supplement_1.S8 Pfaller, 2002, Trends in antifungal susceptibility of Candida spp. Isolated from pediatric and adult patients with bloodstream infections: Sentry antimicrobial surveillance program 1997 to 2000, J. Clin. Microbiol., 40, 852, 10.1128/JCM.40.3.852-856.2002 Pfaller, 2003, In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates, Antimicrob. Agents Chemother., 47, 1068, 10.1128/AAC.47.3.1068-1071.2003 Pfaller, 1998, In vitro susceptibilities of candida bloodstream isolates to the new triazole antifungal agents bms-207147, sch 56592, and voriconazole, Antimicrob. Agents Chemother., 42, 3242, 10.1128/AAC.42.12.3242 Philip, 2003, Syscan3 for the detection of anti-candida antibodies for the diagnosis of invasive candidiasis Phillips, 1997, Prevalence of candida species in hospital-acquired urinary tract infections in a neonatal intensive care unit, Pediatr. Infect. Dis. J., 16, 190, 10.1097/00006454-199702000-00005 Pickering, 2003 Pizzo, 1982, Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia, Am. J. Med., 72, 101, 10.1016/0002-9343(82)90594-0 Rangel-Frausto, 1999, National epidemiology of mycoses survey (nemis): variations in rates of bloodstream infections due to candida species in seven surgical intensive care units and six neonatal intensive care units, Clin. Infect. Dis., 29, 253, 10.1086/520194 Rex, 1994, A randomized trial comparing fluconazole with amphotericin b for the treatment of candidemia in patients without neutropenia. Candidemia study group and the national institute, N. Engl. J. Med., 331, 1325, 10.1056/NEJM199411173312001 Rex, 2000, Practice guidelines for the treatment of candidiasis. Infectious diseases society of america (see comment), Clin. Infect. Dis., 30, 662, 10.1086/313749 Roilides, 2004, Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates, Eur. J. Clin. Microbiol. Infect. Dis., 23, 745, 10.1007/s10096-004-1210-9 Rowen, 2003, Mucocutaneous candidiasis, Semin. Perinatol., 27, 406, 10.1016/S0146-0005(03)00066-1 Rowen, 1994, Endotracheal colonization with candida enhances risk of systemic candidiasis in very low birth weight neonates, J. Pediatr., 124, 789, 10.1016/S0022-3476(05)81375-7 Rowen, 1999, Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility, J. Clin. Microbiol., 37, 3735, 10.1128/JCM.37.11.3735-3737.1999 Sabo, 2000, Voriconazole: a new triazole antifungal, Ann. Pharmacother., 34, 1032, 10.1345/aph.19237 Safe, 1977, Sterol content and polyene antibiotic resistance in isolates of Candida krusei, Candida parakrusei, and Candida tropicalis, Can. J. Microbiol., 23, 398, 10.1139/m77-058 Saiman, 2001, Risk factors for candida species colonization of neonatal intensive care unit patients, Pediatr. Infect. Dis. J., 20, 1119, 10.1097/00006454-200112000-00005 Saiman, 2000, Risk factors for candidemia in neonatal intensive care unit patients. The national epidemiology of mycosis survey study group, Pediatr. Infect. Dis. J., 19, 319, 10.1097/00006454-200004000-00011 Saxen, 1993, Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life, Clin. Pharmacol. Ther., 54, 269, 10.1038/clpt.1993.147 Scarcella, 1998, Liposomal amphotericin b treatment for neonatal fungal infections, Pediatr. Infect. Dis. J., 17, 146, 10.1097/00006454-199802000-00013 Schelonka, 2003, Time to positive culture results in neonatal candida septicemia, J. Pediatr., 142, 564, 10.1067/mpd.2003.188 Sigmundsdottir, 2000, Urine d-arabinitol/l-arabinitol ratio in diagnosis of invasive candidiasis in newborn infants, J. Clin. Microbiol., 38, 3039, 10.1128/JCM.38.8.3039-3042.2000 Sims, 1988, Prophylactic oral nystatin and fungal infections in very-low-birthweight infants, Am. J. Perinatol., 5, 33, 10.1055/s-2007-999649 Smego, 1984, Combined therapy with amphotericin b and 5-fluorocytosine for candida meningitis, Rev. Infect. Dis., 6, 791, 10.1093/clinids/6.6.791 Sokol-Anderson, 1988, Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin b, Antimicrob. Agents Chemother., 32, 702, 10.1128/AAC.32.5.702 Stoll, 1996, Late-onset sepsis in very low birth weight neonates: a report from the national institute of child health and human development neonatal research network, J. Pediatr., 129, 63, 10.1016/S0022-3476(96)70191-9 Stoll, 2002, Late-onset sepsis in very low birth weight neonates: the experience of the nichd neonatal research network, Pediatrics, 110, 285, 10.1542/peds.110.2.285 Stoll, 2004, To tap or not to tap: high likelihood of meningitis without sepsis among very low birth weight infants, Pediatrics, 113, 1181, 10.1542/peds.113.5.1181 Waggoner-Fountain, 1996, Vertical and horizontal transmission of unique candida species to premature newborns, Clin. Infect. Dis., 22, 803, 10.1093/clinids/22.5.803 Wainer, 1992, Prophylactic miconazole oral gel for the prevention of neonatal fungal rectal colonization and systemic infection, Pediatr. Infect. Dis. J., 11, 713, 10.1097/00006454-199209000-00008 Wainer, 1997, Prospective study of fluconazole therapy in systemic neonatal fungal infection, Pediatr. Infect. Dis. J., 16, 763, 10.1097/00006454-199708000-00007 Walsh, T.J., Adamson, P.C., Seibel, N.L., et al., 2002a. Pharmacokinetics of caspofungin in pediatric patients (abstract). In: Paper presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy. Walsh, 2002, Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children, Pediatr. Infect. Dis. J., 21, 240, 10.1097/00006454-200203000-00015 Walsh, 1991, Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis, N. Engl. J. Med., 324, 1026, 10.1056/NEJM199104113241504 Walsh, 1994, Serum d-arabinitol measured by automated quantitative enzymatic assay for detection and therapeutic monitoring of experimental disseminated candidiasis: correlation with tissue concentrations of Candida albicans, J. Med. Vet. Mycol., 32, 205, 10.1080/02681219480000271 Walsh, 1995, New antifungal compounds and strategies for treatment of invasive fungal infections in patients with neoplastic diseases, Cancer Treat. Res., 79, 113, 10.1007/978-1-4613-1239-0_6 Walsh, 1995, Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum d-arabinitol, Am. J. Med., 99, 164, 10.1016/S0002-9343(99)80136-3 Walsh, 1999, Amphotericin b lipid complex in pediatric patients with invasive fungal infections, Pediatr. Infect. Dis. J., 18, 702, 10.1097/00006454-199908000-00010 Weese-Mayer, 1987, Risk factors associated with candidemia in the neonatal intensive care unit: a case–control study, Pediatr. Infect. Dis. J., 6, 190, 10.1097/00006454-198702000-00009 Wells, 1983, Evaluation of serum arabinitol as a diagnostic test for candidiasis, J. Clin. Microbiol., 18, 353, 10.1128/JCM.18.2.353-357.1983 Wenzl, 1998, Pharmacokinetics of oral fluconazole in premature infants, Eur. J. Pediatr., 157, 661, 10.1007/s004310050906 Whelan, 1987, The genetic basis of resistance to 5-fluorocytosine in candida species and cryptococcus neoformans, Crit. Rev. Microbiol., 15, 45, 10.3109/10408418709104447 Yeo, 2002, Current status of nonculture methods for diagnosis of invasive fungal infections, Clin. Microbiol. Rev., 15, 465, 10.1128/CMR.15.3.465-484.2002